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Morphine Modulates Interleukin-4- 
or Breast Cancer Cell-induced 
Pro-metastatic Activation of 
Macrophages
Samira Khabbazi1, Yannick Goumon2 & Marie-Odile Parat1
Interactions between cancer cells and stromal cells in the tumour microenvironment play a key role in 
the control of invasiveness, metastasis and angiogenesis. Macrophages display a range of activation 
states in specific pathological contexts and alternatively activated (M2) macrophages can promote 
tumour aggressiveness. Opioids are able to modulate tumour growth and metastasis. We tested 
whether morphine modulates the activation of macrophages induced by (i) interleukin-4 (IL-4), the 
prototypical M2 polarization-inducing cytokine, or (ii) coculture with breast cancer cells. We showed 
that IL-4 causes increased MMP-9 production and expression of the alternative activation markers 
arginase-1 and MRC-1. Morphine prevented IL-4-induced increase in MMP-9 in a naloxone- and 
methylnaltrexone-reversible fashion. Morphine also prevented IL-4-elicited alternative activation of 
RAW264.7 macrophages. Expression of MMP-9 and arginase-1 were increased when RAW264.7 were 
subjected to paracrine activation by 4T1 cells, and this effect was prevented by morphine via an opioid 
receptor-mediated mechanism. Morphine further decreased 4T1 breast cancer cell invasion elicited by 
co-culture with RAW264.7. Reduction of MMP-9 expression and alternative activation of macrophages 
by morphine was confirmed using mouse bone marrow-derived macrophages. Taken together, our 
results indicate that morphine may modulate tumour aggressiveness by regulating macrophage 
protease production and M2 polarization within the tumour microenvironment.
Opioids display a range of activities that have been proposed to both promote and inhibit tumour growth 
and metastasis1. There is considerable interest in unravelling whether opioids administered in the peri-
operative period to cancer surgery patients can influence tumour recurrence or metastasis2. Opioids are 
both perceived as a threat in the context of cancer (because of their immune suppressive effects, which 
may impair defences against cancer cells3, their pro-angiogenic potential4, and the pro-tumour effects of 
μ opioid receptor5), and as beneficial due to the tumour-promoting effects of pain6, and the anti-tumour 
potential of opioid agonists7,8. Our work has previously shown that morphine regulates the interaction 
between breast cancer cells and stromal cells, and more specifically moderates the paracrine action of 
macrophages on the proteolytic profile of breast cancer cells8. This posed the question of whether mor-
phine could also regulate macrophage phenotype and behaviour. The plasticity of macrophages has been 
the object of recent interest which unveiled their ability to adopt multiple possible phenotypes situated 
between the two extremes of classical (M1) or alternative (M2) activation. In this somewhat simplified 
paradigm, the M1 phenotype, characterized by high expression of pro-inflammatory cytokines and high 
production of reactive oxygen and nitrogen species, has enhanced microbicidal ability and plays an 
important role in the early phase of inflammation, whereas M2 macrophages promote tissue remodelling 
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and resolution of inflammation9,10. In cancer, M1 macrophages exhibit anti-tumour activity while tumour 
progression is associated with, and promoted by, M2 macrophages9. Tumour associated macrophages 
(TAMs) share phenotypical and functional features with M2 macrophages10. IL-4-expressing Th2 lym-
phocytes regulate the phenotype and behaviour of TAMs in vivo, resulting in increased breast cancer 
metastasis11. A recent report challenged the fact that TAMs are alternatively activated12, suggesting fur-
ther complexity in macrophage activation.
In the present study, we employed two separate models of in vitro activation of macrophages, namely 
IL-4 exposure and paracrine activation by breast cancer cells. We assessed the effect of morphine on 
expression of M2 markers and the production of matrix proteases in both experimental models.
Results
Alternative activation of RAW264.7 macrophages by IL-4. IL-4 is documented to be the pro-
totypic cytokine that induces alternative activation of macrophages10. To establish an in vitro model of 
alternative macrophage activation, we incubated RAW264.7 cells with 1 to 20 ng/ml IL-4 in serum-free 
medium for 48 h. The conditioned medium was collected and analysed by gelatine zymography (Fig. 1A). 
At doses of 5, 10 and 20 ng/ml, IL-4 increased the production of MMP-9, while MMP-2 was unaffected. 
The smallest dose tested that induced a statistically significant increase in MMP-9 was 5 ng/ml (Fig. 1B, 
p = 0.0008). The increased expression of MMP-9 in IL-4-treated cells was confirmed using real time 
RT-PCR (Fig.  1C, p = 0.0104). We further confirmed that this concentration of IL-4 (5ng/ml) elicited 
increased expression of the alternative activation markers MRC-1 and arginase-1 (Fig. 1C). The increase 
was statistically significant for both markers (p = 0.0244 and 0.0018, respectively). In our study, as the 
relative increase in expression of arginase-1 was higher than that of MRC-1, we employed arginase-1 
mRNA expression to measure alternative activation of RAW264.7 cells in subsequent experiments.
Morphine prevents IL-4 induced increase in MMP-9 production, and expression of alternative 
activation markers in RAW264.7 macrophages. To test whether morphine affected IL-4 induced 
macrophage M2 polarization, RAW264.7 cells were incubated for 48 h in serum-free medium containing 
either 5 ng/ml IL-4, or 5 ng/ml IL-4 and 20 μ M morphine. Zymography of conditioned media showed that 
morphine prevented the IL-4 induced increase in MMP9 activity (Fig. 2A) and densitometric quantifica-
tion showed that the decrease was statistically significant (Fig. 2B). MMP-2, in contrast, was unaffected 
by IL-4 or morphine (Fig. 2A). The effect of morphine on IL-4-induced MMP-9 was detected at mRNA 
level and statistically significant (p = 0.0032, one way ANOVA) where both 10 and 20 μ M morphine were 
effective (Fig.  2C). Interestingly, morphine also significantly (p = 0.0043, one way ANOVA) prevented 
the induction by IL-4 of the M2 marker arginase-1 (Fig. 2C). In the absence of IL-4, morphine did not 
affect the levels of MMP-9 mRNA (Fig. 2D) but significantly reduced arginase-1 mRNA in RAW264.7 
cells (p = 0.0048, one way ANOVA).
The effect of morphine on IL-4 induced increase in MMP-9 production is reversed by opioid 
receptor antagonists. To test whether the effect of morphine on IL-4 induced macrophage MMP-9 
production was opioid receptor-mediated, RAW264.7 cells were incubated for 48 h in serum-free medium 
containing morphine in the presence or absence of the pure antagonists naloxone or methyl naltrex-
one at equimolar concentrations (20 μ M). Either inhibitor significantly reversed the effect of morphine 
on MMP-9 activity in the conditioned medium (Fig.  3A,B). MMP-2 was unaffected by all treatments 
(Fig.  3A). The reversal of morphine’s effect on IL-4-induced increase in MMP-9 by the inhibitors was 
also evident, and statistically significant, at mRNA level (Fig. 3C). These results indicate that morphine 
prevents IL-4-induced MMP-9 expression via an opioid receptor-mediated pathway.
Paracrine activation of RAW264.7 cells by 4T1 breast cancer cells results in MMP-9 induc-
tion and alternative activation. To test whether increased MMP-9 production and alternative 
activation of macrophages were achieved by paracrine communication with breast cancer cells, we 
placed RAW264.7 cells in the presence of 4T1 cells for 48h using Transwells® . Control cells were grown 
individually. Interaction of the cells resulted in increased production of MMP-9 in the conditioned 
medium (Fig. 4A,B) compared with the medium of individual cells. To assess which cell type is respon-
sible for increased MMP-9 production, RNA was prepared from each cell type and tested by real time 
RT-PCR. Results show that both cell types underwent induction of MMP-9 expression when co-cultured 
(Fig. 4C,D). Lastly, we examined whether RAW264.7 cells underwent alternative activation, and showed 
that the marker arginase-1 was strongly induced when RAW264.7 cells were exposed to paracrine acti-
vation by 4T1 cells (Fig. 4E). This model of M2 activation was next used to test the effect of morphine.
Morphine modulates breast cancer cell-induced alternative activation of RAW264.7 mac-
rophages. RAW264.7 and 4T1 cells were grown together or individually for 48 h using Transwells® 
in the presence of morphine (10 or 20 μ M). Control cells were grown together or individually in the 
absence of morphine. Analysis of the conditioned media by gelatin zymography showed that morphine 
significantly decreased the coculture-induced surge in MMP-9 production (Fig.  5A,B) (p < 0.01, two 
way ANOVA) but had no effect on the production of MMP-9 by cells grown individually. The decrease 
in coculture-induced MMP-9 expression by RAW264.7 was detected at mRNA level (Fig. 5C) and was 
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statistically significant (p = 0.0268, one way ANOVA). Lastly, we tested whether morphine prevented the 
alternative activation of RAW264.7 induced by coculture with 4T1 cells and showed that the increase in 
RAW264.7 arginase-1 production was significantly (p < 0.0001, one way ANOVA) reduced by morphine 
(Fig. 5D).
The effect of morphine on coculture-induced increase in MMP-9 production is reversed by 
opioid receptor antagonists. To test whether the effect of morphine on 4T1-induced macrophage 
MMP-9 production was opioid receptor-mediated, RAW264.7 cells were incubated for 48 h in the presence 
of 4T1 in Transwells® in serum-free medium containing morphine (20 μ M) in the presence or absence 
of naloxone or methyl naltrexone at equimolar concentrations (20 μ M). Either inhibitor significantly 
Figure 1. Alternative activation of RAW264.7 macrophages by IL-4. A) Production of gelatinases MMP-9 
and MMP-2 in the conditioned medium of RAW264.7 cells treated with indicated concentrations of IL-4 
for 48 h was assessed by gelatine zymography. B) RAW264.7 cells were treated with 5 ng/ml IL-4 for 48 h 
and gelatinase production determined by zymography followed by densitometric quantitation of MMP-9 
and MMP-2. Mean ± SEM is shown, n  = 3 independent experiments. ***p < 0.001; ns, no statistically 
significant difference, Student’s t-test C) Real-time RT-PCR determination of mRNA levels of MMP-9 as well 
as alternative activation markers MRC-1 and arginase-1 (Arg-1) in RAW264.7 cells treated with 5 ng/ml IL-4 
for 48h. Results are expressed relative to untreated control. Mean ± SEM is shown, n = 7–10 independent 
experiments. *p < 0.05, **p < 0.01, Student’s t-test.
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Figure 2. Morphine inhibits IL-4 induced increase of MMP-9 production by RAW264.7 macrophages. 
A) RAW264.7 macrophages were incubated with IL-4 (5 ng/ml) in the presence or absence of morphine 
(20 μ M). Control cells were incubated with buffer alone. Conditioned media were tested for gelatinase 
production by zymography. B) Zymography gels were subjected to densitometric quantitation of MMP-9. 
Mean ± SEM is shown, n = 3 separate experiments. ****p < 0.0001, Student’s t-test. ; C) Real-time RT-PCR 
determination of mRNA levels of MMP-9 and alternative activation marker arginase-1 (Arg-1) or MRC-1 in 
RAW264.7 cells treated with 5 ng/ml IL-4 and either 0, 10 or 20 μ M morphine for 48 h. Results are expressed 
relative to IL-4 only treated cells. Mean ± SEM is shown, n = 3–6 independent experiments. *p < 0.05; 
**p < 0.01; ns, no statistical significance, One way ANOVA with Dunnet’s multiple comparison test. D) Real-
time RT-PCR determination of mRNA levels of MMP-9 or alternative activation marker arginase-1 (Arg-1) 
in RAW264.7 cells treated with 0, 10 or 20 μ M morphine for 48h. Results are expressed relative to untreated 
control. Mean ± SEM is shown, n = 4 independent experiments. ns, no statistical significance; *p < 0.05, 
One way ANOVA with Dunnet’s multiple comparison test.
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reversed the effect of morphine on MMP-9 activity in the conditioned medium (Fig. 5E,F). These results 
confirm that the effect of morphine on macrophage MMP-9 expression is opioid receptor-mediated.
Morphine prevents coculture-induced increase in breast cancer cell invasion. To assess 
whether the effect of morphine on MMP-9 production had functional consequences, we tested the abil-
ity of 4T1 cells to invade basement membrane-like substrate. The cells were seeded in matrigel-coated 
inserts placed in the absence or presence of RAW264.7 cells in the bottom chamber. In the presence of 
macrophage cells, breast cancer cell invasion was increased by a factor ~13 (Fig. 6A,B). This was signif-
icantly reduced if morphine was added to the co-culture (Fig. 6A,B).
Morphine prevents IL-4 and coculture-induced increase in MMP-9, Arg-1 and MRC-1 in bone 
marrow derived mouse macrophages. To confirm key results obtained using the RAW264.7 cell 
line, we tested the effect of morphine on IL-4- or 4T1 coculture-induced mRNA expression of MMP-9, 
Arg-1 and MRC-1. Of note, experiments were performed using 24 h rather than 48 h time points as BMM 
cannot sustain a 48 h no-serum medium exposure. Both IL-4 (Fig. 7A) and co-culture with 4T1 (Fig. 7C) 
markedly induced the expression of the three markers, although no statistical significance was reached 
for Arg-1 and MMP-9 in the case of co-cultures (Fig. 7C). One way ANOVA analysis showed that mor-
phine significantly inhibited the IL-4-induced induction of Arg-1 (p = 0.0296) MMP-9 (p = 0.0225) and 
MRC-1 (p = 0.0212) (Fig.  7B). Morphine also significantly inhibited the coculture-induced expression 
of Arg-1 (p = 0.003) MMP-9 (p = 0.0111) and MRC-1 (p = 0.0014) (Fig. 7D). Furthermore the effect of 
morphine on BMM was observed with much lower doses (starting as low as 100 nM) than in the exper-
iments using RAW264.7 cells.
Discussion
Our results show a marked increase in MMP-9 expression, as detected by gelatine zymography and real 
time RT-PCR, when RAW264.7 macrophages are exposed to the M2 polarization-inducing cytokine 
IL-4 or when they are co-cultured with breast cancer cells in separate chambers. In contrast to MMP-9, 
there was remarkably no change in MMP-2 in the conditioned medium in either activation model. In 
the context of tumours, increased MMP-9 is considered to promote invasiveness and angiogenesis, by 
degradation of the extracellular matrix (ECM) and basement membrane, liberation of matrix-bound 
growth factors and activation of tumour-promoting agents13. Secretion of MMP-9 by tumour-associated 
macrophages is well documented (reviewed in14) and we have previously shown that plating RAW264.7 
Figure 3. The effect of morphine is opioid receptor-mediated. RAW264.7 macrophages were incubated 
for 48`h with IL-4 (5 ng/ml) in the presence or absence of morphine (20 μM) and naloxone (20 μM) or 
methylnaltrexone (MNTX) (20 μM) as indicated. A) Conditioned media were collected and analysed by 
gelatine zymography. B) Zymography gels were used for densitometric quantitation. Mean ± SEM is shown, 
n = 5 independent experiments. *p < 0.05; ***p < 0.001; ****p < 0.0001, Student’s t test. C) Real-time RT-
PCR determination of mRNA levels of MMP-9 in RAW264.7 cells treated as indicated. Results are expressed 
relative to IL-4 only treated cells. Mean ± SEM is shown, n = 5 independent experiments. *p < 0.05; 
**p < 0.01; ***p < 0.001, Student’s t test.
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macrophages and breast cancer cells in contact in coculture altered their proteolytic profile, including 
increase of MMP-9 production8. The link between macrophage exposure to IL-4 and MMP-9 produc-
tion is less clear, with literature indicating that IL-4 suppresses rather than induces the expression of 
MMP-9 in macrophages15–18. Discrepancies in MMP production have been attributed to in vitro differ-
entiation techniques, plastic or cell-cell contact19. In agreement with our data Lolmede et al. reported 
increased MMP-9 production in ex vivo polarized human macrophages20. Furthermore, we have previ-
ously reported that 4T1 tumour-bearing mice exhibit increased circulating MMP-98.
In vivo, morphine prevented the increase in circulating MMP-9 elicited by 4T1 tumours8. We now 
show that morphine prevents the increase in MMP-9 elicited by the cross talk between macrophages 
and breast cancer cells. This corroborates our previous results obtained when cells were in contact in 
the same dish, or when 4T1 cells were exposed to medium that had been conditioned by RAW264.78. 
Using Transwells® however, allows reciprocal communication and thus cross talk amplification of signals 
exchanged between the two cell populations, and the preparation of RNA from each cell type separately 
to assess their individual contribution to the surge in MMP-9 production. Both 4T1 and RAW264.7 
increased transcription of MMP-9, in response to reciprocal paracrine activation. Morphine decreased 
MMP-9 production in the conditioned medium of co-cultured cells without affecting MMP-9 pro-
duction in cells grown individually. This is in favour of a modulating role for opioids in the tumour 
microenvironment where they can prevent the matrix degradation (and thus invasion and angiogenesis) 
resulting from cancer cells’ cross talk with stromal macrophages. The ability of morphine to decrease 
macrophage-induced invasion of basement membrane like substrate corroborates this. In addition, 
morphine prevented IL-4-induced increase in MMP-9 production, indicating that opioids may prevent 
Figure 4. MMP-9 production is increased in Transwell® co-cultures of macrophages and 4T1 cells. 
RAW264.7 macrophages (in the lower chamber) and 4T1 cells (in the upper chamber) were cultured 
individually or together for 48 h in 12-well Transwell®. A) Conditioned media were collected and production 
of MMP-9 was determined by gelatine zymography. B) Densitometric quantitation of MMP-9 activity in 
the conditioned media. Mean ± SEM is shown. n = 3 independent experiments ***p < 0.001 compared to 
4T1 or RAW264.7 alone, Student’s t test. C-D) Real-time PCR determination of MMP-9 mRNA levels in 
RAW264.7 cells (C) and 4T1 cells (D) alone or co-cultured for 48h. Results are expressed relative to each 
cell type grown individually. Mean ± SEM is shown, n = 3 independent experiments. *p < 0.05, Student’s t 
test. E) Real-time PCR determination of arginase-1 mRNA levels of RAW264.7 cells co-cultured with 4T1 
cells for 48 h. Results are expressed relative to RAW264.7 grown individually. Mean ± SEM is shown, n = 3 
independent experiments. **p < 0.01, Student’s t test.
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IL-4-expressing Th2 lymphocytes from promoting macrophage activation in the tumour microenviron-
ment.
In their recent study, Doornebal et al. quantified and analysed the composition of infiltrating immune 
cells in mouse breast tumours and showed, using two distinct mouse models, that morphine did not 
decrease the absolute number of tumour leucocytes or the proportion of infiltrating macrophages21. 
Our finding that morphine qualitatively changes macrophage phenotype in the context of cancer 
is novel. Morphine decreased the cancer cell coculture- or IL-4-induced expression of arginase-1 in 
Figure 5. Morphine inhibits coculture-induced increase in MMP-9 production by RAW264.7 
macrophages. RAW264.7 macrophages (in the lower chamber) and 4T1 cells (in the upper chamber) were 
cultured individually or together for 48 h in 12-well Transwell® in the presence (10 or 20 μ M as indicated) 
or absence of morphine. A) Production of MMP-9 in the conditioned media was determined by gelatine 
zymography. B) Densitometric quantitation of MMP-9 activity in the conditioned media. Results are 
expressed as a % of MMP9 in 4T1 alone. Mean ± SEM is shown. n = 3 independent experiments *p < 0.05; 
***p < 0.001, Two way ANOVA with Tukey’s multiple comparisons test. C) Real-time PCR determination 
of MMP-9 mRNA levels in RAW264.7 cells co-cultured for 48 h with 4T1 in the presence (10 or 20 μ M as 
indicated) or absence of morphine. Results are expressed relative to RAW264.7 cells co-cultured with 4T1 
in the absence of morphine. Mean ± SEM is shown, n = 3 independent experiments. *p < 0.05, One way 
ANOVA with Dunnet’s multiple comparisons test. D) Real-time PCR determination of arginase-1 (Arg-1) 
mRNA levels in RAW264.7 cells co-cultured for 48 h with 4T1 in the presence (10 or 20 μ M as indicated) 
or absence of morphine. Results are expressed relative to RAW264.7 cells co-cultured with 4T1 in the 
absence of morphine. Mean ± SEM is shown, n = 3 independent experiments. ***p < 0.001. ****p < 0.0001, 
One way ANOVA with Dunnet’s multiple comparisons test. E–F, RAW264.7 macrophages (in the lower 
chamber) and 4T1 cells (in the upper chamber) were cultured together for 48 h in 12-well Transwell® in the 
presence of morphine (20 μ M) and naloxone (20 μ M) or methylnaltrexone (MNTX) (20 μ M) as indicated. E) 
Conditioned media were collected and analysed by gelatine zymography. F) Zymography gels were used for 
densitometric quantitation. Mean ± SEM is shown, n = 3 independent experiments. *p < 0.05; ***p < 0.001, 
Student’s t test.
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RAW264.7 or bone marrow derived macrophages. This is in agreement with the finding that the endog-
enous opioid peptide methionine enkephalin (a δ - and to a lesser extent μ -opioid receptor agonist) 
down-regulates the production of M2 markers CD206 and arginase-1 in tumour associated macrophages 
in vivo22. Interestingly, in our experiments while morphine had no effect on MMP-9 production unless 
the cells were activated by either IL-4 or breast cancer cells, morphine decreased arginase-1 expression 
in RAW264.7 macrophages in the absence of stimulation. The effect of opioids on macrophage pheno-
type might therefore not be limited to the tumour microenvironment inflammatory milieu. In a recent 
report by Godai et al. using a tumour-free model, morphine administered locally tilted the balance of 
macrophages present at a site of incisional inflammation towards the M2 phenotype23. Of note, this effect 
was only seen in the early phase of inflammation (day 2).
The ability of morphine to reduce arginase-1 expression in IL-4- or 4T1 breast cancer cell-activated 
macrophages is likely to be beneficial in the context of tumours. Arginase activity results in the pro-
duction of polyamines which promote breast cancer cell proliferation24. By competing with nitric oxide 
synthase (NOS) for arginine as a common substrate, arginase-1 can inhibit nitric oxide (NO) production 
in LPS-activated macrophages25, and NO production is considered to be important for the anti-tumour 
activity of macrophages. Recently, myeloid cell-specific deletion of arginase-1 in mice was shown to 
improve residual disease control in a transient window of time after therapy26.
In our experiments, morphine prevented MMP-9 increase and arginase-1 induction in both models of 
activation (treatment with IL-4 and coculture with cancer cells) in RAW264.7 and BMM cells. Together 
with other cell types, Th2 lymphocytes are believed to be a major source of IL-4 in the tumour microen-
vironment, leading to activation of macrophages10,11. We have mimicked this by directly applying IL-4 on 
RAW264.7 cells in vitro. In addition, interaction with breast cancer cells induced MMP-9 and arginase-1. 
This could be due to IL-4, as cancer cells are also a source of IL-4 capable of eliciting alternative mac-
rophage activation27,28.
Our results show that both naloxone and methylnaltrexone inhibit the effect of morphine on IL-4- or 
4T1 coculture-induced MMP-9 production by macrophages, in favour of an opioid receptor-mediated 
action. A previous study showing that morphine decreased mRNA expression of MMP-9 in cultured 
breast cancer cells showed no reversal by equimolar naloxone29. Although the experimental design is not 
comparable to our study because the effect of morphine was not tested in response to a MMP-9-inducing 
factor but in un-stimulated cells, this is a reminder that morphine exerts both opioid-mediated and 
-independent effects at cellular level. Our data does not unveil the downstream mechanism by which 
opioid activation results in modulation of MMP-9, Arg-1 and (in BMM) MRC-1 mRNA expression. 
We have tested whether the effect of morphine involved STAT-6, a major regulator of IL-4-induced 
macrophage M2 polarization9. Our results (data not shown) confirmed the strong increase in STAT-6 
phosphorylation in IL-4-treated RAW264.7 cells, but this was unaffected by morphine, excluding STAT-6 
as a mediator of opioid action in our model.
Morphine modulates tumour growth and metastasis via multiple mechanisms, some of which are 
likely to promote, others likely to prevent, cancer aggressiveness1,30. The results presented in this study 
indicate that morphine may attenuate the invasion-promoting effects of IL-4 or the paracrine interaction 
between macrophages and cancer in the context of a tumour microenvironment.
Materials And Methods
Materials. Coomassie blue (Coomassie Brilliant Blue R-250) was from Bio-Rad (Gladesville, NSW, 
Australia). Cell culture media, serum and supplements were from Life Technologies, Mulgrave, VIC, 
Australia. Morphine and naloxone were from Hospira (Mulgrave, VIC, Australia). Methylnaltrexone was 
Figure 6. Morphine prevents macrophage-induced breast cancer cell invasion. Invasion of matrigel-
coated inserts by 4T1 cells over 48 h was allowed to proceed in the absence or presence of RAW264.7 
cells seeded in the bottom well of the chamber, and of 20 μM morphine as indicated. A) Representative 
images of invaded cells after fixation and staining. B) Quantification of invaded cells. Mean ± SEM is shown, 
n = 3 independent experiments. **p < 0.01; ***p < 0.001, Student’s t test.
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Figure 7. Morphine inhibits alternative activation of bone marrow-derived macrophages (BMM). A) BMM 
were treated with 5 ng/ml IL-4 for 24 h and mRNA expression of MMP-9 and the M2 polarization markers 
Arg-1 and MRC-1 was assessed by real-time RT-PCR. Results are expressed relative to untreated control. 
Mean ± SEM is shown, n = 4 independent experiments. **p < 0.01, ***p < 0.001, Student’s t-test. B) BMM 
were incubated with IL-4 (5 ng/ml) in the presence or absence of morphine at the indicated concentrations 
(up to 20 μ M) for 24 h and mRNA expression of Arg-1 MMP-9 or MRC-1 was determined by real time RT-
PCR. Results are expressed relative to IL-4 only treated cells. Mean ± SEM is shown, n = 3–4 independent 
experiments. *p < 0.05; **p < 0.01 ns, no statistical significance, One way ANOVA with Dunnet’s multiple 
comparison test. C) BMM and 4T1 cells were cultured individually or together for 24 h in 12-well Transwell® 
and mRNA levels of Arg-1, MMP-9 and MRC-1 determined by real time RT-PCR in BMM alone or co-
cultured with 4T1 cells. Results are expressed relative to BMM grown individually. Mean ± SEM is shown, 
n = 3–4 independent experiments. *p < 0.05, Student’s t test. D) BMM were co-cultured with 4T1 in the 
presence or absence of morphine at the indicated concentrations (up to 20 μ M) for 24 h and mRNA expression 
of Arg-1 MMP-9 or MRC-1 determined by real time RT-PCR. Results are expressed relative to BMM co-
cultured with 4T1 in the absence of morphine. Mean ± SEM is shown, n = 3–4 independent experiments. 
*p < 0.05; **p < 0.01, ***p < 0.001, ns, no statistical significance, One way ANOVA with Dunnet’s multiple 
comparison test.
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from Link Medical Products (Warriewood, NSW, Australia). Unless otherwise stated, all other reagents 
were from Sigma-Aldrich (Castle Hill, NSW, Australia).
Cell culture. Mouse RAW264.7 macrophages were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% (v/v) foetal bovine serum (FBS), penicillin (100 units/ml) 
and streptomycin (100 μ g/ml). Murine mammary breast carcinoma cells (4T1) were maintained in 
Roswell Park Memorial Institute medium (RPMI-1640) containing 5% FBS (v/v), 1% sodium pyruvate 
(v/v), penicillin (100 units/ml) and streptomycin (100 μ g/ml). Bone marrow (BM) was isolated from 
femurs of 12 week-old C57BL/6l mice following procedures approved by the University of Queensland 
Animal Welfare Unit Ethics Committee (571/12). Bone marrow-derived macrophages (BMDM) were 
generated by culture of BM for 6 days in DMEM containing 20% L929 cell-conditioned media, 10% 
heat-inactivated foetal bovine serum, 1mM sodium pyruvate, 2 mM L-glutamine and 10 mM HEPES. 
Fresh media was added on days 2 and 4 of culture. All cells were incubated in a humidified atmosphere 
at 37o C with 5% CO2.
Polarization of macrophages. RAW264.7 or BMM cells were seeded at 2 × 105 cells per well in a 12 
well plate with 1 ml of serum-containing DMEM and incubated overnight. The cells were incubated with 
serum-free medium containing 0–20 ng/ml recombinant murine IL-4 (PeproTech, Rocky Hill, NJ, USA) 
to induce alternatively activated macrophage (M2) polarization. After 24 h (BMM) or 48 h (RAW264.7) 
incubation, conditioned media and cells were collected for gelatine zymography and real-time reverse 
transcriptase polymerase chain reaction (Real time RT-PCR), respectively.
Co-cultures. Mouse macrophages and 4T1 cells were seeded individually or together in equal num-
bers (1 × 105 cells) in a 12-well plate Transwell® system with a porous polycarbonate membrane filter 
(0.4  μ M pore size, Corning, NSW, Australia) in a 1:1 mix of complete medium of each cell line for 18 h. 
The medium was replaced with a 1:1 mix of serum-free RPMI and DMEM media, and cells incubated 
with 10–20  μ M DBL® morphine sulfate (Mulgrave, VIC, Australia). The 48 h (RAW264.7 and 4T1) or 
24 h (BMM) conditioned media and cells were collected, tested for gelatine zymography and real time 
RT-PCR, respectively.
Gelatine zymography. Conditioned media were analysed for gelatinases (MMP-2 and MMP-9) quan-
tification level using gelatine zymography as described previously8. Briefly, equal protein amount (as 
measured using Bio-Rad DCTM Protein assay) of the conditioned media were loaded on an 11% poly-
acrylamide gel containing 1% (w/v) gelatine and separated electrophoretically in non-reducing condi-
tions. The gels were placed in a renaturing solution containing 5 mM CaCl2, 50 mM Tris and 2.5% (v/v) 
Triton X-100 overnight. The gel was then incubated in a solution of 5 mM CaCl2 and 50 mM Tris–HCl at 
35 °C for 3 h to allow enzyme activity. After Coomassie staining (45% (v/v) methanol, 10% (v/v) glacial 
acetic acid and 0.25% (w/v) Coomassie Blue R-250) the gel was destained with a solution containing 10% 
(v/v) acetic acid and 25% (v/v) methanol until areas containing the proteolytic enzymes appeared as clear 
bands on a dark background. Band intensity was determined following high-resolution flatbed scanning 
and image analysis using Image J software.
Invasion assay. 24 h prior to the assay, RAW264.7 cells (2 × 105 cells) were seeded in the bottom 
chamber of a 24-well plate. Moreover, 4T1 cells were incubated in serum-free RPMI medium. 4T1 
cells were harvested and 1 × 105 cells were added to the upper chamber of a BME coated polycar-
bonate (PC) membrane filter chamber (8 μ M pore size, BioScientific Pty Ltd, Sydney, N.S.W.). The 
medium was replaced with a 1:1 mix of serum-free RPMI and DMEM media. Morphine sulfate (DBL® 
Mulgrave, VIC, Australia) was added to upper and bottom chamber at a concentration of 20 μ M. 
Invasion was allowed to proceed for 48 h. A negative control was set up where 4T1 cells were seeded 
in the upper chamber with no RAW264.7 in the bottom well. After incubation the inserts were washed 
with PBS twice and fixed with buffered formalin (ALPHELYS, Plaisir, France) for 20 min. The mem-
branes then were stained overnight using crystal violet (Sigma-Aldrich, Castle Hill, NSW, Australia). 
Inserts were imaged in their centre at 20X magnification and cells per field were quantified in three 
independent experiments.
Quantitative RT-PCR. Total RNA derived from RAW264.7 and 4T1 cells was isolated and purified 
using the RNeasy Plus Mini Kit (Qiagen, VIC, Australia). RNA (600–2000 ng) was reverse transcribed 
using the Omniscript RT Kit (Qiagen, VIC, Australia) and amplified using TaqMan® Fast Universal PCR 
Master Mix (Life Technologies, VIC, Australia) with AmpliTaq Gold® DNA Polymerase, and TaqMan® 
Gene Expression Assays including Arginase-1 (Mm00475988_m1), MMP-9 (Mm00442991_m1) and 
MRC-1 (Mm00485148_m1) in a StepOnePlus 7500 real time PCR system (Applied Biosystems, Carlsbad, 
CA, USA). Quantification was performed relative to 18S ribosomal RNA using the comparative critical 
threshold (Ct) method31 and relative expression of the target gene measured in at least three separate 
experiments was compared with the appropriate control.
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Statistical analysis. Data are presented as mean values ± S.E.M and were analysed, using Graphpad 
Prism software (version 5.04). Differences between single group means with control means were analysed 
using one tailed Student’s t-test and one-way or two-way analysis of variance (ANOVA) where appropri-
ate. Differences were considered statistically significant at p < 0.05.
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